BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25601544)

  • 1. NDR functions as a physiological YAP1 kinase in the intestinal epithelium.
    Zhang L; Tang F; Terracciano L; Hynx D; Kohler R; Bichet S; Hess D; Cron P; Hemmings BA; Hergovich A; Schmitz-Rohmer D
    Curr Biol; 2015 Feb; 25(3):296-305. PubMed ID: 25601544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.
    Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the hippo signaling pathway in human gastric cancer.
    Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
    Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.
    Li P; Silvis MR; Honaker Y; Lien WH; Arron ST; Vasioukhin V
    Genes Dev; 2016 Apr; 30(7):798-811. PubMed ID: 27013234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
    Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
    J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
    Subramaniam D; Ponnurangam S; Ramalingam S; Kwatra D; Dandawate P; Weir SJ; Umar S; Jensen RA; Anant S
    Cells; 2021 Jun; 10(7):. PubMed ID: 34206989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDR Kinases Are Essential for Somitogenesis and Cardiac Looping during Mouse Embryonic Development.
    Schmitz-Rohmer D; Probst S; Yang ZZ; Laurent F; Stadler MB; Zuniga A; Zeller R; Hynx D; Hemmings BA; Hergovich A
    PLoS One; 2015; 10(8):e0136566. PubMed ID: 26305214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MICAL-1 is a negative regulator of MST-NDR kinase signaling and apoptosis.
    Zhou Y; Adolfs Y; Pijnappel WW; Fuller SJ; Van der Schors RC; Li KW; Sugden PH; Smit AB; Hergovich A; Pasterkamp RJ
    Mol Cell Biol; 2011 Sep; 31(17):3603-15. PubMed ID: 21730291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDR kinase is activated by RASSF1A/MST1 in response to Fas receptor stimulation and promotes apoptosis.
    Vichalkovski A; Gresko E; Cornils H; Hergovich A; Schmitz D; Hemmings BA
    Curr Biol; 2008 Dec; 18(23):1889-95. PubMed ID: 19062280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
    Guo C; Wang X; Liang L
    Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.
    Kodaka M; Hata Y
    Cell Mol Life Sci; 2015 Jan; 72(2):285-306. PubMed ID: 25266986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.
    Zhou D; Conrad C; Xia F; Park JS; Payer B; Yin Y; Lauwers GY; Thasler W; Lee JT; Avruch J; Bardeesy N
    Cancer Cell; 2009 Nov; 16(5):425-38. PubMed ID: 19878874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E
    Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
    Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
    Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOB1 regulates thymocyte egress and T-cell survival in mice in a YAP1-independent manner.
    Kato W; Nishio M; To Y; Togashi H; Mak TW; Takada H; Ohga S; Maehama T; Suzuki A
    Genes Cells; 2019 Jul; 24(7):485-495. PubMed ID: 31125466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Protein Interactions by
    Xiong S; Couzens AL; Kean MJ; Mao DY; Guettler S; Kurinov I; Gingras AC; Sicheri F
    Mol Cell Proteomics; 2017 Jun; 16(6):1111-1125. PubMed ID: 28373297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases.
    Devroe E; Erdjument-Bromage H; Tempst P; Silver PA
    J Biol Chem; 2004 Jun; 279(23):24444-51. PubMed ID: 15067004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.
    Chen Q; Zhang N; Xie R; Wang W; Cai J; Choi KS; David KK; Huang B; Yabuta N; Nojima H; Anders RA; Pan D
    Genes Dev; 2015 Jun; 29(12):1285-97. PubMed ID: 26109051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.